Thomas C. Reynolds, Chief Medical Officer at SEATTLE GENETICS INC /WA (SGEN), sold 30,000 shares at $25.25 ($760K) on 2012-11-21, disclosed to the SEC on 2012-11-26.
Open-market sale of $760k SGEN by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.25 | 10,000 | $253K | 33.2% |
| 2 | $25.26 | 10,000 | $253K | 33.2% |
| 3 | $25.50 | 7,000 | $179K | 23.5% |
| 4 | $25.50 | 3,000 | $77K | 10.1% |
| Total | $25.34 avg | 30,000 | $760K | 100% |
| Filing → |
| SGEN | SELL | 2013-01-17 | $3.5M | — | Filing → |
| SGEN | SELL | 2012-12-10 | $1.7M | — | Filing → |
| SGEN | SELL | 2012-12-06 | $1.0M | — | Filing → |